圣达生物
(603079)
| 流通市值：23.31亿 | | | 总市值：23.31亿 |
| 流通股本：1.89亿 | | | 总股本：1.89亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 389,057,542.5 | 189,216,336.68 | 844,536,869.9 | 621,284,743.25 |
| 营业收入 | 389,057,542.5 | 189,216,336.68 | 844,536,869.9 | 621,284,743.25 |
| 二、营业总成本 | 358,794,109.64 | 171,919,634.54 | 764,169,196.49 | 555,173,218.95 |
| 营业成本 | 280,617,314.09 | 136,989,484.37 | 623,663,243.68 | 459,539,665.95 |
| 税金及附加 | 5,871,873.71 | 2,557,771.03 | 11,005,878.21 | 8,054,006.37 |
| 销售费用 | 6,508,630.29 | 2,773,898.2 | 15,022,582.84 | 9,681,901.37 |
| 管理费用 | 36,222,125.62 | 17,514,056.91 | 65,679,473.81 | 47,344,909.47 |
| 研发费用 | 23,782,721.79 | 10,088,210.12 | 53,674,165.67 | 35,568,859.94 |
| 财务费用 | 5,791,444.14 | 1,996,213.91 | -4,876,147.72 | -5,016,124.15 |
| 其中:利息费用 | 2,048,472.56 | 115,416.16 | 908,928.02 | 863,818.11 |
| 其中:利息收入 | 4,030,986.51 | 1,949,754.33 | 8,455,343.76 | 6,395,360.85 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 54,817.38 | -1,008.8 | 49,263.4 | 302.64 |
| 加:投资收益 | 2,157,615.22 | 906,428.53 | 2,064,913.51 | 1,325,624.94 |
| 资产处置收益 | -563,488.57 | - | -477,311.75 | -125,651.57 |
| 资产减值损失(新) | -887,329.32 | -794,071.33 | -10,153,834.42 | -1,922,160.02 |
| 信用减值损失(新) | -39,752.6 | 150,886.03 | -639,807.94 | -556,275.8 |
| 其他收益 | 2,169,151.72 | 1,018,007.68 | 9,003,115.06 | 7,406,654.21 |
| 四、营业利润 | 33,154,446.69 | 18,576,944.25 | 80,214,011.27 | 72,240,018.7 |
| 加:营业外收入 | 181,958.95 | 63,520.99 | 630,888.74 | 467,218 |
| 减:营业外支出 | 1,454,744.52 | 58,286.56 | 717,562.97 | 607,716.71 |
| 五、利润总额 | 31,881,661.12 | 18,582,178.68 | 80,127,337.04 | 72,099,519.99 |
| 减:所得税费用 | 7,360,085.78 | 3,268,446.11 | 10,862,997.37 | 13,372,448.84 |
| 六、净利润 | 24,521,575.34 | 15,313,732.57 | 69,264,339.67 | 58,727,071.15 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 24,521,575.34 | 15,313,732.57 | 69,264,339.67 | 58,727,071.15 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 20,527,534.56 | 13,174,688.97 | 62,155,711.5 | 53,338,557.65 |
| 少数股东损益 | 3,994,040.78 | 2,139,043.6 | 7,108,628.17 | 5,388,513.5 |
| 扣除非经常损益后的净利润 | 18,921,937.84 | 12,077,749.26 | 56,113,547.49 | 47,487,685.97 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.11 | 0.07 | 0.35 | 0.3 |
| (二)稀释每股收益 | 0.11 | 0.07 | 0.35 | 0.3 |
| 九、综合收益总额 | 24,521,575.34 | 15,313,732.57 | 69,264,339.67 | 58,727,071.15 |
| 归属于母公司股东的综合收益总额 | 20,527,534.56 | 13,174,688.97 | 62,155,711.5 | 53,338,557.65 |
| 归属于少数股东的综合收益总额 | 3,994,040.78 | 2,139,043.6 | 7,108,628.17 | 5,388,513.5 |
| 公告日期 | 2026-08-28 | 2026-04-27 | 2026-04-27 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |